Literature DB >> 15995791

What is the pain of interstitial cystitis like?

M P FitzGerald1, C Brensinger, L Brubaker, K Propert.   

Abstract

To describe the characteristics of pain experienced by patients with interstitial cystitis (IC) in terms of pain site, severity, and character, we performed a secondary analysis of data from the IC database (ICDB), which was a prospective, longitudinal, cohort study of IC patients. We analyzed the cross-sectional baseline data from 629 patients who had a completed baseline symptom questionnaire. Patients answered questions about whether they had pain or discomfort associated with urinary symptoms over the past 4 weeks and if so, about the location, characteristics, intensity, and frequency of their pain. Logistic regression examined associations between pain location and the presence of urinary symptoms. Analyses were performed using SAS version 8.2 (SAS Institute, Cary, NC, USA) and considered significant at the 5% level. Five hundred and eighty-nine (94%) patients with a mean age of 45 years (SD 14 years) reported baseline pain or discomfort associated with their urinary symptoms. The most common baseline pain site was lower abdominal (80%), with urethral (74%) and low back pain (65%) also commonly reported. The majority of patients described their pain as intermittent, regardless of the pain site. Most patients reported moderate pain intensity, across all pain sites. There was a statistically significant link between pain in the urethra, lower back, and lower abdomen, and urinary symptoms. Patients with IC report pain at several sites other than the bladder, possibly arising from the previously well-described myofascial abnormalities of pelvic floor and abdominal wall present in patients with IC and other chronic pelvic pain syndromes.

Entities:  

Mesh:

Year:  2005        PMID: 15995791     DOI: 10.1007/s00192-005-1344-z

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  5 in total

1.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

2.  Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987.

Authors:  J Y Gillenwater; A J Wein
Journal:  J Urol       Date:  1988-07       Impact factor: 7.450

Review 3.  The Interstitial Cystitis Data Base Study: concepts and preliminary baseline descriptive statistics.

Authors:  L J Simon; J R Landis; D R Erickson; L M Nyberg
Journal:  Urology       Date:  1997-05       Impact factor: 2.649

4.  Epidemiology of interstitial cystitis.

Authors:  J A Koziol
Journal:  Urol Clin North Am       Date:  1994-02       Impact factor: 2.241

5.  Pelvic floor myofascial trigger points: manual therapy for interstitial cystitis and the urgency-frequency syndrome.

Authors:  J M Weiss
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

  5 in total
  16 in total

1.  Myofascial pain and pelvic floor dysfunction in patients with interstitial cystitis.

Authors:  Renee Bassaly; Natalie Tidwell; Siobhan Bertolino; Lennox Hoyte; Katheryne Downes; Stuart Hart
Journal:  Int Urogynecol J       Date:  2010-10-26       Impact factor: 2.894

2.  Assessing urgency in interstitial cystitis/painful bladder syndrome.

Authors:  Christina Diggs; Walter A Meyer; Patricia Langenberg; Patty Greenberg; Linda Horne; John W Warren
Journal:  Urology       Date:  2007-01-31       Impact factor: 2.649

3.  The genetic and environmental contribution to the occurrence of bladder pain syndrome: an empirical approach in a nationwide population sample.

Authors:  Daniel Altman; Cecilia Lundholm; Ian Milsom; Ralph Peeker; Magnus Fall; Anastasia N Iliadou; Nancy L Pedersen
Journal:  Eur Urol       Date:  2010-11-05       Impact factor: 20.096

4.  Characterization of Whole Body Pain in Urological Chronic Pelvic Pain Syndrome at Baseline: A MAPP Research Network Study.

Authors:  H Henry Lai; Thomas Jemielita; Siobhan Sutcliffe; Catherine S Bradley; Bruce Naliboff; David A Williams; Robert W Gereau; Karl Kreder; J Quentin Clemens; Larissa V Rodriguez; John N Krieger; John T Farrar; Nancy Robinson; J Richard Landis
Journal:  J Urol       Date:  2017-03-31       Impact factor: 7.450

5.  Comparison of baseline urological symptoms in men and women in the MAPP research cohort.

Authors:  J Quentin Clemens; Daniel J Clauw; Karl Kreder; John N Krieger; John W Kusek; H Henry Lai; Larissa Rodriguez; David A Williams; Xiaoling Hou; Alisa Stephens; J Richard Landis
Journal:  J Urol       Date:  2014-11-13       Impact factor: 7.450

6.  Association of neuropathic pain with bladder, bowel and catastrophizing symptoms in women with bladder pain syndrome.

Authors:  Lori Cory; Heidi S Harvie; Gina Northington; Anna Malykhina; Kristene Whitmore; Lily Arya
Journal:  J Urol       Date:  2011-12-15       Impact factor: 7.450

7.  Evidence-based criteria for pain of interstitial cystitis/painful bladder syndrome in women.

Authors:  John W Warren; Jessica Brown; J Kathleen Tracy; Patricia Langenberg; Ursula Wesselmann; Patty Greenberg
Journal:  Urology       Date:  2008-03       Impact factor: 2.649

Review 8.  Treatment approaches for painful bladder syndrome/interstitial cystitis.

Authors:  Theoharis C Theoharides
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Pain in interstitial cystitis/bladder pain syndrome: do characteristics differ in ulcerative and non-ulcerative subtypes?

Authors:  Kim A Killinger; Judith A Boura; Kenneth M Peters
Journal:  Int Urogynecol J       Date:  2012-12-04       Impact factor: 2.894

Review 10.  Evidence for overlap between urological and nonurological unexplained clinical conditions.

Authors:  María Angeles Bullones Rodríguez; Niloofar Afari; Dedra S Buchwald
Journal:  J Urol       Date:  2009-09-16       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.